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Abstract
Kindler Syndrome (KS) is an autosomal recessive skin disorder characterized by skin blistering 
and photosensitivity. KS is caused by loss of function mutations in FERMT1, which encodes 
Kindlin-1. Kindlin-1 is a FERM domain containing adaptor protein that is found predominantly 
at cell-extracellular matrix adhesions where it binds to integrin β subunits and is required for 
efficient integrin activation. Using keratinocytes derived from a patient with KS, into which 
wild type Kindlin-1 (Kin1WT) has been expressed, we show that Kindlin-1 binds to cyclin-
dependent kinase (CDK)1 and CDK2. CDK1 and CDK2 are key regulators of cell cycle 
progression, however, cell cycle analysis showed only small differences between the KS and 
KS-Kin1WT keratinocytes. In contrast, G2/M cell cycle arrest in response to oxidative stress 
induced by hydrogen peroxide (H2O2) was enhanced in KS keratinocytes but not KS-Kin1WT 
cells, following inhibition of CDK activity. Furthermore, KS keratinocytes were more sensitive 
to DNA damage in response to H2O2 and this was exacerbated by treatment with the CDK 
inhibitor roscovitine. Thus, in Kindlin-1 deficient keratinocytes, CDK activity can further 
regulate oxidative damage induced cell cycle arrest and DNA damage. This provides further 
insight into the key pathways that control sensitivity to oxidative stress in KS patients.
KEYWORDS
CDK1, CDK2, Kindlin-1, cell cycle, DNA damage
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1 BACKGROUND
Kindlin-1 is one of three closely related proteins (Kindlin-1, -2 and -3) consisting primarily of 
a four.1, ezrin, radixin and moesin (FERM) domain split by a pleckstrin homology domain.[1] 
Kindlins play a key role in connecting dynamic actin regulation with membrane 
rearrangements at the leading edge of motile cells through their ability to regulate integrin 
activation.[2, 3] Loss of function mutations in the FERMT1 gene, which encodes Kindlin-1 leads 
to an autosomal skin disorder called KS.[4, 5] Patients with KS show photosensitivity, skin 
blistering in sun-exposed areas and poikiloderma.[5-7] Disruption of integrin-dependent 
functions of Kindlin-1 have been implicated in a number of pathologies associated with KS but 
there remain many questions about how loss of Kindlin-1 regulates the behaviour of 
keratinocytes and the aetiology of KS. 
2          QUESTIONS ADDRESSED
Previously we have shown that Kindlin-1 can translocate to centrosomes, where it regulates 
mitotic spindle formation and can regulate cell division in the skin of mice.8, 9 We therefore 
asked whether Kindlin-1 binds the cell cycle regulators CDK1 and CDK2. Furthermore, we 
addressed whether the increased sensitivity of KS keratinocytes to oxidative damage was 
regulated by inhibition of CDK activity.
3 EXPERIMENTAL DESIGN
Immortalized human keratinocytes from a patient harbouring a FERMT1 mutation 
(c.676insC/c.676insC) were used in this study.[10] To address Kindlin-1 dependent effects wild-
type Kindlin1-mCherry was expressed in the KS keratinocytes to generate KS-Kin1WT 
keratinocytes. Detailed protocols are provided in Data S1. Comparison of cell cycle profiles 
was carried out with the ImageXpress Micro XLS High-content analysis system by grouping 
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DAPI stained nuclei according to size and brightness of the DAPI signal. RFP-trap pull downs 
combined with western blotting was used to assess binding of Kindlin-1 to CDK1 and CDK2. 
To induce oxidative stress cells were treated with H2O2 and phosphorylation of histone H2AX, 
used as a marker of DNA damage, was analyzed by immunofluorescence. To assess the role of 
CDKs in response to H2O2, the pan-CDK inhibitor roscovitine was used.
3 RESULTS
3.1 Kindlin-1 binds CDKs
As we had previously identified a role for Kindlin-1 in mitotic progression[8, 9] we looked at 
the interaction between Kindlin-1 and CDKs. RFP-trap agarose beads were used to pull down 
RFP-Kindlin-1 in KS-Kin1WT keratinocytes using KS keratinocytes as a control. Western 
blotting showed that both CDK1 and the structurally similar CDK2 associated with Kindlin-1 
(Figure 1A). Using recombinant CDK1 and CDK2 we were able to show a direct interaction 
with Kindlin-1 (Figure S1A). To confirm binding of Kindlin-1 to CDK1/2 we used a mouse 
squamous cell carcinoma model in which Kindlin-1 had been genetically deleted (SCC-Kin-1-
/-) as detailed in Data S1.[17] Immunoprecipitation of CDK1 or CDK2 from SCC-Kin-1-/- cells 
and SCC-Kin-1WT cells in which Kindlin-1 had been re-expressed, showed that Kindlin-1 
associated with both CDK1 and CDK2 (Figure S1A). This was more evident for CDK2 which 
likely reflects the greater expression of CDK2 in the immunoprecipitates (Figure S1B). 
We then looked at the expression of both CDK1 and CDK2 and other cell cycle associated 
proteins in the KS and KS-Kin1WT keratinocytes. There were no differences in the levels of 
CDK1 or CDK2 in the two cell lines with the most striking difference being the 
phosphorylation of CDK1 on tyrosine (Tyr) 15, which was significantly lower in the KS 
keratinocytes (Figure 1B,C). 
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3.2 Effect of Kindlin-1 on cell cycle progression
Dephosphorylation on Tyr15 is the critical regulatory step in activating CDK1[11] and to 
determine whether this change in phosphorylation was associated with changes in cell cycle 
progression, we analysed the cell cycle in the keratinocytes. In KS keratinocytes there was a 
small decrease in the percentage of cells in G1 compared to the KS-Kin1WT cells, which was 
accompanied by an increase in G2/M, both of which were not statistically significant (Figure 
1D-F). Furthermore, there was no difference in the proliferation of the KS and KS-Kin1WT 
keratinocytes (Figure 1G). 
As the effects on the cell cycle were small we asked whether cell cycle arrest in response to 
DNA damage was altered and whether this was dependent on CDK activity using the CDK 
inhibitor roscovitine. Roscovitine is a pan-CDK inhibitor, which inhibits CDK1, CDK2 and 
CDK5.[12, 13] H2O2 induces cell cycle arrest, with sublethal doses leading to G2/M cell cycle 
arrest.[14, 15] Treatment with a low concentration of H2O2 resulted in a small decrease in G1 with 
an accompanying increase in G2/M in both KS and KS-Kin1WT keratinocytes (Figure 2A). 
Treatment with both H2O2 and roscovitine however, led to a further decrease in G1 and a 
concomitant increase in G2/M in KS keratinocytes, which was not seen in the KS-KinWT 
keratinocytes, resulting in a significant difference in cell cycle arrest between the KS and KS-
Kin1WT cells (Figure 2A-C). Treatment with roscovitine reduced phosphorylation of 
retinoblastoma protein (Rb), demonstrating inhibition of CDK activity (Figure 2D). Thus, in 
the absence of Kindlin-1, cells have an increased dependence on CDK activity for stress-
induced cell cycle arrest.
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3.4  Kindlin-1 loss and CDK inhibition synergize to induce DNA damage
Another important function of CDKs is to regulate the cellular response to DNA damage.[16] 
We know from previous studies that Kindlin-1 deficient cells are more sensitive to oxidative 
stress and that they exhibit more DNA damage after oxidative stress.[17] To gain further insight 
into the biological significance of CDKs in this Kindlin-1-dependent response, we analyzed 
DNA damage following treatment with H2O2 in the presence or absence of roscovitine. 
Treatment with H2O2 led to increased accumulation of nuclear phosphorylated H2AX in KS 
but not KS-Kin1WT cells (Figure 2E, F). Treatment with both roscovitine and H2O2 led to a 
further increase in DNA damage in the Kindlin-1 deficient keratinocytes compared to the KS-
Kin1WT cells (Figure 2E-G). Thus, the increased sensitivity of the Kindlin-1 deficient 
keratinocytes to DNA damage is exacerbated following inhibition of CDK activity, indicating 
that in the absence of Kindlin-1 CDK activity can alter the DNA damage response. Similar 
results were seen in the Kindlin-1 deficient SCC cells, with roscovitine treatment leading to 
increased levels of DNA damage induced by H202 in the SCC-Kin-1-/- cells compared to the 
SCC-Kin-1WT (Figure S1B,C).
4 CONCLUSIONS
  
Kindlin-1 is important for integrin activation: integrins are transmembrane receptors that link 
the extracellular matrix to the actin cytoskeleton.[18, 19] Integrins can cooperate with growth 
factor receptors to regulate cell cycle progression and proliferation[20] by cooperatively 
inducing PI3K/AKT, MEK/ERK and small GTPase signalling.[19, 21] However, the proximal 
integrin downstream signals controlling cell cycle progression are poorly understood. 
Interestingly, ILK, another focal adhesion protein that has been identified as a binding partner 
of Kindlin-1, functions downstream of integrins and may be a critical regulator of integrin-
mediated cell cycle progression.[22] This is the first report of an adhesion linked protein binding 
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to CDKs although CDK1 has been shown to phosphorylates a number of proteins (including 
Kindlin-2) that are involved in regulation of adhesion complexes and the actin cytoskeleton, 
indicating a role for CDK1 cell cycle-dependent regulation of adhesion [23, 24].
The cell cycle profile of Kindlin-1 deficient keratinocytes did not differ significantly from 
that of the Kindlin-1 expressing cells. In addition, Kindlin-1 deficiency did not alter 
keratinocyte proliferation indicating that Kindlin-1 is not required for cell cycle progression in 
this model. Similar results were seen in the SCC model used in this study where loss of Kindlin-
1 did not impact on proliferation in 2D culture (V.G.B, manuscript in preparation). This is in 
contrast to our previous report in mouse skin where Kindlin-1 deficiency resulted in a reduction 
in proliferation.[8] In addition, previous studies have reported proliferation defects in Kindlin-
1 deficient keratinocytes when compared to normal human keratinocytes.[25, 26] This indicates 
that there are context dependent differences in the requirement for Kindlin-1 in cell cycle 
progression and proliferation and that other integrin proximal signals may be able to 
compensate for loss of Kindlin-1. 
CDKs also play an important role in controlling the response to DNA damage and we show 
that roscovitine, a pan-CDK inhibitor, can exacerbate both the cell cycle arrest and DNA 
damage induced by H2O2 in KS keratinocytes. This has previously been reported for 
roscovitine in the context of DNA damage induced by chemotherapeutic agents.[27, 28] CDK1 
is involved in the DNA double-strand break homologous recombination repair pathway. 
Inhibition of CDK activity by roscovitine arrests cells in G2/M and primes them for DNA 
damage which is associated with reduced recruitment of homologous recombination 
proteins.[27] Both CDK1 and PLK1, which we have previously identified as a Kindlin-1 binding 
partner[9], are involved in the regulation of DNA double strand break repair by non-homologous 
end joining (NHEJ) through phosphorylation of 53BP1.[29] This raises the intriguing possibility 
that Kindin-1 may play an adaptor function in pathways that regulate DNA damage repair.
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Keratinocytes from KS patients are more prone to oxidative stress[30] and have increased 
sensitivity to UV irradiation.[17, 31] A number of Kindlin-1 dependent signaling pathways linked 
to increased sensitivity in the KS keratinocytes have been identified[17, 31] but here we show 
that Kindlin-1 binding partners also play an important role. Photosensitivity manifests early in 
life in KS patients and is a distressing clinical feature of the disease. Understanding the 
underlying mechanisms that control DNA damage repair pathways in the absence of Kindlin-
1 will help identify potential approaches to alleviate the photosensitivity in KS patients.
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FIGURE LEGENDS
FIGURE 1  Kindlin-1 binds CDKs but does not alter cell cycle progression. A, Western blot 
analysis of RFP-trap immunoprecipitates and whole cell lysates (WCL) in KS and KS-Kin1WT 
keratinocytes. B, Western blot analysis of cell cycle regulators in KS and KS-Kin1WT 
keratinocytes. C, Quantification of pCDK1 levels relative to actin. Results represent the 
quantification and s.e.m. of 3 independent experiments. *p<0.05, statistically significant 
difference after one-sample student t-test. D, Cell cycle profiles of KS and KS-Kin1WT 
keratinocytes. E, F Relative changes in G2/M (E) and G1 (F) in KS-Kin1WT compared to KS 
keratinocytes. Results represent the mean and s.e.m. of 4 independent experiments. *p<0.05, 
statistically significant difference after one-sample student t-test. G, Quantification of KS and 
KS-Kin1WT cell number over time. 
FIGURE 2  Loss of Kindlin-1 and inhibition of CDKs sensitize cells to cell cycle arrest and 
oxidative damage in response to hydrogen peroxide. A, Cell cycle profiles of KS and KS-
Kin1WT keratinocytes treated with roscovitine and 250 μM H2O2. B, C Relative change of G1 
(B) and G2/M (C) between cells treated with both roscovitine and H2O2 to the untreated control. 
Data was further normalized to KS. Results represent the mean and s.e.m. of 4 independent 
experiments. *p<0.05, **p<0.01, statistically significant difference after paired two-sample t-
test. D, Western blot analysis of pRb in KS and KS-Kin1WT keratinocytes treated with 
roscovitine. Actin was used as a loading control. E, F DNA damage measured by pH2AX 
immunofluorescence staining in KS and KS-Kin1WT keratinocytes treated with roscovitine 
and 250 μM H2O2. Quantification of nuclear pH2AX fluorescence intensity normalized to 
nuclear DAPI (E) and representative images of pH2AX (green) and DAPI (blue) to visualize 
nuclei (F). G, Increase in DNA damage normalized to Kindlin-1 expressing cells and H2O2 
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treatment. Results represent the mean and s.e.m. of at least 3 independent experiments. 
*p<0.05, statistically significant difference from control value after one-sample student t-test. 
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Data S1
1.1 Cell culture
Kindlin-1 was sub-cloned into pHR9SIN-SEW lentiviral expression vector containing an N-
terminal mCherry tag. Lentiviral DNA was transfected with the Δ8.91 packaging plasmid and 
pMD2.G envelope plasmid into HEK293 cells for lentiviral particle production. Virus was 
harvested and used to infect target keratinocytes. Expressing cells were further selected for 
expression using FACS and maintained for further passages under identical conditions to non-
infected cells (Zhang et al., 2016). Keratinocytes were cultivated in KSF-M (Thermo Fisher) 
at 37°C and 5% CO2. For the proliferation assay, 250 cells were counted and plated in 6-well 
plates. Cells were trypsinized and counted each day for up to 7 days. Generation of SCC-Kin1-
/- and SCC-Kin1WT cells was previously described (Emmert et al., 2017). SCCs were induced 
in K14CreERT2 Kin1flox/flox mice using a two-stage chemical skin carcinogenesis protocol as 
previously described (McLean et al., 2004). Following surgical excision of carcinomas, small 
tissue pieces were adhered to tissue culture plates and cells allowed to grow out in DMEM 
supplemented with 2 mM L-glutamine, 1 mM sodium pyruvate and 10% foetal bovine serum 
(FBS). To induce Kindlin-1 deletion SCC cells were cultured in the presence of 15 μM 4-
hydroxytamoxifen (4OHT) for 24 hours. Cells were then trypsinized and single cells seeded 
into each well of a 96-well plate and allowed to establish colonies. Resulting colonies were 
screened for genetic deletion of Fermt1 (SCC-Kin1-/-). Wild-type Kindlin-1 (SCC-Kin1WT) 
was cloned into pWZL-Hygro retroviral vector and introduced into the SCC-Kin1-/- cells or 
the empty vector and stable pools selected in 0.25 mg/ml hygromycin. SCC cells were 
cultivated at 37°C and 5% CO2 in DMEM with 10% FBS. Cells were used at passages 3–20.
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1.2 Immunoprecipitation and western blotting
Sub-confluent cells were washed twice in ice-cold PBS and lysed in RIPA buffer (50 mM Tris 
pH 8.0, 150 mM NaCl, 1% TritonX-100, 0.5% sodium deoxycholate, 0.1% SDS) containing 
protease and phosphatase inhibitors (Roche, 04906845001 and 04693124001, respectively) at 
4oC. For RFP-trap pull downs 500 μg lysate was incubated with RFP-trap agarose beads 
(Chromotek) at room temperature for 45 minutes, washed three times in lysis buffer and three 
times in PBS. For CDK1 and CDK2 immunoprecipitates 500 μg lysate was incubated with 
either IgG (Cell Signaling Technology #2729), CDK1 (Cell Signaling Technology #9116) or 
CDK2 (Cell Signaling Technology #2546) antibodies in PBS containing 0.1% Triton-X 100 
(PBST) for 30 minutes at room temperature. Samples were washed three times in lysis buffer 
and three times in PBS. Immunoprecipitates, RFP-trap pull downs or whole cell lysates were 
separated according to size using SDS–PAGE, transferred onto nitrocellulose membrane, and 
blocked for 1 hour in TBS containing 0.05% Tween-20 (TBST) and 5% BSA. Membranes 
were incubated over night at 4°C and for 45 minutes at room temperature for primary and 
secondary antibodies, respectively. All washes and antibody incubations were carried out in 
TBST and TBST plus 5% BSA. Antibodies used were: Actin (Cell Signaling Technology 
#3700), Kindlin-1 (Abcam #ab68041), CDK1 (Cell Signaling Technology #9116), pCDK1 
(Cell Signaling Technology #9111), CDK2 (Cell Signaling Technology #2546), pRb (Cell 
Signaling Technology #9307), CDK6, CyclinD1, CyclinD3, p21 (Cell Signaling Technology 
regulation kit #9932). Primary antibodies were used at 1:1000 and dye secondary antibodies 
were used as directed by the manufacturer (Licor).
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1.3       Recombinant protein pull-downs
Kindlin-1 (Origene TP317593) was incubated with 20 μl HIS-Select Nickel Affinity Gel 
(Sigma H0537) alone or in the presence of 200 ng recombinant HIS-tagged CDK1 (Abbexa 
abx066201) or 200 ng recombinant HIS -tagged CDK2 (Abbexa abx066204) in 25 mM HEPES 
pH 7.4, 150 mM NaCl, 1% Triton X-100, 1.5 mM MgCl2, 1 mM EGTA with protease and 
phosphatase inhibitors (Roche 5892970001 and 4906845001) for 1 hour at 4oC with rotation. 
Beads were washed three times with the above buffer and twice in PBS. 10 μl Laemelli buffer 
was added to the beads and boiled for 5 minutes at 95oC before performing western blotting as 
described above with anti-Kindlin-1 antibody.
1.4 Induction of oxidative stress
To induce oxidative stress cells were treated with hydrogen peroxide (H2O2) (Merck, #31642). 
For H2O2 treatment media was replaced with freshly prepared media containing 250 μM H2O2. 
In control cells the media was switched to fresh media without H2O2. In experiments where 
roscovitine was used, roscovitine was added at a final concentration of 20 μM for 16 hours 
(Cell Signaling Technology #9885) prior to H2O2 treatment.
1.5 H2AX Assay
Cells grown on coverslips were fixed with Fix-buffer (100 mM PIPES, 3.7% 
paraformaldehyde, 0.2% Triton X-100, 1 mM MgCl2, and 10 mM EGTA, pH 7.4) for 10 
minutes and washed three times in Wash buffer (TBS plus 0.1% Triton X-100). The incubation 
with primary antibodies was at 4oC overnight in Wash buffer plus 2% BSA. Cover slips were 
washed twice in Wash buffer and incubated with the secondary antibodies for 90 minutes at 
room temperature in Wash buffer plus 2% BSA. Cover slips were mounted with Vectashield 
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Mounting Media containing DAPI (Vector Laboratories). Images were captured using an FV-
1000 Olympus confocal microscope using a 40× objective. The primary pH2AX antibody was 
used 1:200 (Cell Signaling Technology #9718) and the dye (Alexa Fluor)-conjugated 
secondary antibody was used at 1:400. For quantification cell nuclei were manually selected in 
ImageJ to create a mask. A mask was then used to measure fluorescence intensity of both the 
DAPI and the pH2AX channel. pH2AX intensity was normalized to the DAPI signal for each 
image. For each biological replicate at least 3 images and a total of at least 30 cells each per 
condition were taken.
1.6 Cell cycle analysis
For the cell cycle analysis 5000 keratinocytes were seeded in 96 well plates. Treatment with 
inhibitors and H2O2 was conducted as described above. Plates were fixed with 4% 
paraformaldehyde for 20 minutes at room temperature and then stained with DAPI. Plates were 
imaged using the ImageXpress Micro XLS High-content analysis system analysing the DAPI 
signal. Analysis of the cell cycle profile was carried out using the inbuilt software by grouping 
cell nuclei according to size and brightness of the DAPI signal. 
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May, 21st, 2019
EXD-18-0352.R3 - Inhibition of cyclin-dependent kinase activity exacerbates H202-induced DNA damage in Kindler syndrome keratinocytes
Dear editor,
Jayne Culley was added as a co-author, as she has conducted experiments and 
contributed new data to the revised manuscript.
Thank you.
Kind regards,
Hila Emmert
Valerie Brunton
Jayne Culley
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